The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Prostaglandin‐cytokine crosstalk in chronic inflammation
Open accessAbstract
Chronic inflammation underlies various debilitating disorders including autoimmune, neurodegenerative, vascular and metabolic diseases as well as cancer, where aberrant activation of the innate and acquired immune systems is frequently seen. Since non‐steroidal anti‐inflammatory drugs exert their effects by inhibiting COX and suppressing PG biosynthesis, PGs have been traditionally thought to function mostly as mediators of acute inflammation. However, an inducible COX isoform, COX‐2, is often highly expressed in tissues of the chronic disorders, suggesting an as yet unidentified role of PGs in chronic inflammation. Recent studies have shown that in addition to their short‐lived actions in acute inflammation, PGs crosstalk with cytokines and amplify the cytokine actions on various types of inflammatory cells and drive pathogenic conversion of these cells by critically regulating their gene expression. One mode of such PG‐mediated amplification is to induce the expression of relevant cytokine receptors, which is typically observed in Th1 cell differentiation and Th17 cell expansion, events leading to chronic immune inflammation. Another mode of amplification is cooperation of PGs with cytokines at the transcription level. Typically, PGs and cytokines synergistically activate NF‐κB to induce the expression of inflammation‐related genes, one being COX‐2 itself, which makes PG‐mediated positive feedback loops. This signalling consequently enhances the expression of various NF‐κB‐induced genes including chemokines to macrophages and neutrophils, which enables sustained infiltration of these cells and further amplifies chronic inflammation. In addition, PGs are also involved in tissue remodelling such as fibrosis and angiogenesis. In this article, we review these findings and discuss their relevance to human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Harding, S. D., Sharman, J. L., Faccenda, E., Southan, C., Pawson, A. J., Ireland, S., Gray, A. J. G., Bruce, L., Alexander, S. P. H., Anderton, S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1121 · Cited by 1,646
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,277
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Self-citationProstaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Induction and molecular signature of pathogenic TH17 cells
Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2416 · Cited by 1,174
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, I. I., Littman, D. R., Maloy, K. J., & Powrie, F. (2010) · Nature · doi:10.1038/nature08949 · Cited by 1,067
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Klose, C. S. N., & Artis, D. (2016) · Nature Immunology · doi:10.1038/ni.3489 · Cited by 951
The Australo-Anglo-American Spondyloarthritis Consortium (TASC), Evans, D. M., the Wellcome Trust Case Control Consortium 2 (WTCCC2), Spondyloarthritis Research Consortium of Canada (SPARCC), Spencer, C. C. A., Pointon, J. J., Su, Z., Harvey, D., Kochan, G., Oppermann, U., et al. (2011) · Nature Genetics · doi:10.1038/ng.873 · Cited by 893
International Genetics of Ankylosing Spondylitis Consortium (IGAS) (2013) · Nature Genetics · doi:10.1038/ng.2667 · Cited by 860
Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
Betz, M., & Fox, B. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.108 · Cited by 821
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 767
Prostaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Self-citationThe CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector
Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, J. R., Takemori, H., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.015 · Cited by 648
TH2 cell development and function
Walker, J. A., & McKenzie, A. N. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.118 · Cited by 632
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13877 · Cited by 597
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: g protein-coupled receptors
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13878 · Cited by 588
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Self-citationYao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto, Y., & Narumiya, S. (2009) · Nature Medicine · doi:10.1038/nm.1968 · Cited by 566
Self-citationTherapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030058 · Cited by 560
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122308 · Cited by 529
Genetic insights into common pathways and complex relationships among immune-mediated diseases
Parkes, M., Cortes, A., van Heel, D. A., & Brown, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3502 · Cited by 526
Hoda, S. A., & Cheng, E. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx095 · Cited by 521
Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Katoh, H., Wang, D., Daikoku, T., Sun, H., Dey, S. K., & DuBois, R. N. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.009 · Cited by 477
Xue, L., Salimi, M., Panse, I., Mjösberg, J. M., McKenzie, A. N. J., Spits, H., Klenerman, P., & Ogg, G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.056 · Cited by 475
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · PubMed · Cited by 451
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Self-citationThe dichotomous nature of T helper 17 cells
Stockinger, B., & Omenetti, S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.50 · Cited by 402
Role of Prostaglandins in Ulcerative Colitis
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · Gastroenterology · doi:10.1016/s0016-5085(19)31672-5 · Cited by 388
Inflammation and Intracranial Aneurysms
Chyatte, D., Bruno, G., Desai, S., & Todor, D. R. (1999) · Neurosurgery · doi:10.1097/00006123-199911000-00024 · Cited by 334
Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021408 · Cited by 325
Self-citationKabashima, K., Sakata, D., Nagamachi, M., Miyachi, Y., Inaba, K., & Narumiya, S. (2003) · Nature Medicine · doi:10.1038/nm872 · Cited by 316
Self-citationBarron, L., & Wynn, T. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00414.2010 · Cited by 304
Sheibanie, A. F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., & Ganea, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8138 · Cited by 284
Grainger, J. R., Wohlfert, E. A., Fuss, I. J., Bouladoux, N., Askenase, M. H., Legrand, F., Koo, L. Y., Brenchley, J. M., Fraser, I. D. C., & Belkaid, Y. (2013) · Nature Medicine · doi:10.1038/nm.3189 · Cited by 264
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Hammitzsch, A., Tallant, C., Fedorov, O., O’Mahony, A., Brennan, P. E., Hay, D. A., Martinez, F. O., Al-Mossawi, M. H., de Wit, J., Vecellio, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501956112 · Cited by 254
Hinds, D. A., McMahon, G., Kiefer, A. K., Do, C. B., Eriksson, N., Evans, D. M., St Pourcain, B., Ring, S. M., Mountain, J. L., Francke, U., et al. (2013) · Nature Genetics · doi:10.1038/ng.2686 · Cited by 246
Aronoff, D. M., Canetti, C., Serezani, C. H., Luo, M., & Peters-Golden, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.595 · Cited by 241
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., & Dayer, J.-M. (2008) · Blood · doi:10.1182/blood-2008-05-155408 · Cited by 235
Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3
Kunikata, T., Yamane, H., Segi, E., Matsuoka, T., Sugimoto, Y., Tanaka, S., Tanaka, H., Nagai, H., Ichikawa, A., & Narumiya, S. (2005) · Nature Immunology · doi:10.1038/ni1188 · Cited by 221
Self-citationTait Wojno, E. D., Monticelli, L. A., Tran, S. V., Alenghat, T., Osborne, L. C., Thome, J. J., Willis, C., Budelsky, A., Farber, D. L., & Artis, D. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.21 · Cited by 213
Honda, T., Segi-Nishida, E., Miyachi, Y., & Narumiya, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051310 · Cited by 208
Self-citationCoulombe, F., Jaworska, J., Verway, M., Tzelepis, F., Massoud, A., Gillard, J., Wong, G., Kobinger, G., Xing, Z., Couture, C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.013 · Cited by 206
Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195
Aoki, T., Nishimura, M., Matsuoka, T., Yamamoto, K., Furuyashiki, T., Kataoka, H., Kitaoka, S., Ishibashi, R., Ishibazawa, A., Miyamoto, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01358.x · Cited by 193
Self-citationThromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity
Kabashima, K., Murata, T., Tanaka, H., Matsuoka, T., Sakata, D., Yoshida, N., Katagiri, K., Kinashi, T., Tanaka, T., Miyasaka, M., et al. (2003) · Nature Immunology · doi:10.1038/ni943 · Cited by 191
Self-citationOga, T., Matsuoka, T., Yao, C., Nonomura, K., Kitaoka, S., Sakata, D., Kita, Y., Tanizawa, K., Taguchi, Y., Chin, K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2066 · Cited by 190
Self-citationSuppression of LPS-Induced TNF-α Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105
Wall, E. A., Zavzavadjian, J. R., Chang, M. S., Randhawa, B., Zhu, X., Hsueh, R. C., Liu, J., Driver, A., Bao, X. R., Sternweis, P. C., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000202 · Cited by 188
Prostaglandin E 2 constrains systemic inflammation through an innate lymphoid cell–IL-22 axis
Duffin, R., O’Connor, R. A., Crittenden, S., Forster, T., Yu, C., Zheng, X., Smyth, D., Robb, C. T., Rossi, F., Skouras, C., et al. (2016) · Science · doi:10.1126/science.aad9903 · Cited by 182
Self-citationTHE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13876 · Cited by 177
Aoki, T., Frȍsen, J., Fukuda, M., Bando, K., Shioi, G., Tsuji, K., Ollikainen, E., Nozaki, K., Laakkonen, J., & Narumiya, S. (2017) · Science Signaling · doi:10.1126/scisignal.aah6037 · Cited by 174
Self-citationProstaglandin E2 induces IL‐23 production in bone marrow‐derived dendritic cells
Sheibanie, A. F., Tadmori, I., Jing, H., Vassiliou, E., & Ganea, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-1367fje · Cited by 171
Khayrullina, T., Yen, J.-H., Jing, H., & Ganea, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.721 · Cited by 170
Brazil, J. C., Louis, N. A., & Parkos, C. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f54e · Cited by 168
Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
Nakanishi, M., Montrose, D. C., Clark, P., Nambiar, P. R., Belinsky, G. S., Claffey, K. P., Xu, D., & Rosenberg, D. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6100 · Cited by 167
Prostaglandin E 2 Suppresses Bacterial Killing in Alveolar Macrophages by Inhibiting NADPH Oxidase
Serezani, C. H., Chung, J., Ballinger, M. N., Moore, B. B., Aronoff, D. M., & Peters-Golden, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0153oc · Cited by 166
A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci
Kenny, E. E., Pe’er, I., Karban, A. A., Ozelius, L. J., Mitchell, A. A., Ng, S. M. E., Erazo, M., D, H. O. M., Abraham, C., Abreu, M. T., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002559 · Cited by 163
Role of prostanoids in gastrointestinal cancer
Wang, D., & DuBois, R. N. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97953 · Cited by 158
Napolitani, G., Rodríguez, E. V. A., Lanzavecchia, A., & Sallusto, F. (2009) · European Journal of Immunology · doi:10.1002/eji.200838969 · Cited by 154
Prostacyclin protects against elevated blood pressure and cardiac fibrosis
Francois, H., Athirakul, K., Howell, D. N., Dash, R., Mao, L., Kim, H., Rockman, H. A., FitzGerald, G. A., Koller, B. H., & Coffman, T. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.005 · Cited by 151
Sheibanie, A. F., Khayrullina, T., Safadi, F. F., & Ganea, D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22794 · Cited by 151
Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751
Arimura, A., Yasui, K., Kishino, J., Asanuma, F., Hasegawa, H., Kakudo, S., Ohtani, M., & Arita, H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29398-8 · Cited by 142
Prostaglandin E2 suppresses human group 2 innate lymphoid cell function
Maric, J., Ravindran, A., Mazzurana, L., Björklund, Å. K., Van Acker, A., Rao, A., Friberg, D., Dahlén, S.-E., Heinemann, A., Konya, V., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.09.050 · Cited by 140
Ma, X., Aoki, T., Tsuruyama, T., & Narumiya, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0125 · Cited by 139
Self-citationTargeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis
Kihara, Y., Matsushita, T., Kita, Y., Uematsu, S., Akira, S., Kira, J., Ishii, S., & Shimizu, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906891106 · Cited by 137
Oshima, H., Hioki, K., Popivanova, B. K., Oguma, K., van Rooijen, N., Ishikawa, T., & Oshima, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.007 · Cited by 131
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses
Zhou, W., Toki, S., Zhang, J., Goleniewksa, K., Newcomb, D. C., Cephus, J. Y., Dulek, D. E., Bloodworth, M. H., Stier, M. T., Polosuhkin, V., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1793oc · Cited by 131
Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis
Chang, J. E., Doherty, T. A., Baum, R. E., & Broide, D. H. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.020 · Cited by 129
COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis
Lovgren, A. K., Jania, L. A., Hartney, J. M., Parsons, K. K., Audoly, L., FitzGerald, G. A., Tilley, S. L., & Koller, B. H. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00492.2005 · Cited by 127
Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis
Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi‐Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 120
Self-citationYao, C., Hirata, T., Soontrapa, K., Ma, X., Takemori, H., & Narumiya, S. (2013) · Nature Communications · doi:10.1038/ncomms2684 · Cited by 117
Self-citationLee, J., Aoki, T., Thumkeo, D., Siriwach, R., Yao, C., & Narumiya, S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.036 · Cited by 117
Self-citationPaulissen, S. M. J., van Hamburg, J. P., Davelaar, N., Asmawidjaja, P. S., Hazes, J. M. W., & Lubberts, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300274 · Cited by 116
Krause, P., Bruckner, M., Uermösi, C., Singer, E., Groettrup, M., & Legler, D. F. (2008) · Blood · doi:10.1182/blood-2008-05-157123 · Cited by 114
Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype
Birrell, M. A., Maher, S. A., Dekkak, B., Jones, V., Wong, S., Brook, P., & Belvisi, M. G. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206592 · Cited by 113
Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP
Shishikura, K., Horiuchi, T., Sakata, N., Trinh, D., Shirakawa, R., Kimura, T., Asada, Y., & Horiuchi, H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13373 · Cited by 106
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
Erpenbeck, V. J., Popov, T. A., Miller, D., Weinstein, S. F., Spector, S. L., Magnusson, B., Osuntokun, W., Goldsmith, P., Weiss, H., & Beier, J. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.06.005 · Cited by 105
Prüß, H., Rosche, B., Sullivan, A. B., Brommer, B., Wengert, O., Gronert, K., & Schwab, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055859 · Cited by 103
Role of Prostaglandin I2 in Airway Remodeling Induced by Repeated Allergen Challenge in Mice
Nagao, K., Tanaka, H., Komai, M., Masuda, T., Narumiya, S., & Nagai, H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0035oc · Cited by 99
Self-citationEastman, J. J., Cavagnero, K. J., DeConde, A. S., Kim, A. S., Karta, M. R., Broide, D. H., Zuraw, B. L., White, A. A., Christiansen, S. C., & Doherty, T. A. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.023 · Cited by 96
Mizuno, R., Kamioka, Y., Kabashima, K., Imajo, M., Sumiyama, K., Nakasho, E., Ito, T., Hamazaki, Y., Okuchi, Y., Sakai, Y., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132112 · Cited by 95
Chen, Q., Muramoto, K., Masaaki, N., Ding, Y., Yang, H., Mackey, M., Li, W., Inoue, Y., Ackermann, K. E., Shirota, H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00647.x · Cited by 93
Yang, C.-W., & Unanue, E. R. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122183 · Cited by 89
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2
Domingo-Gonzalez, R., Martínez-Colón, G. J., Smith, A. J., Smith, C. K., Ballinger, M. N., Xia, M., Murray, S., Kaplan, M. J., Yanik, G. A., & Moore, B. B. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0161oc · Cited by 85
Díaz‐Muñoz, M. D., Osma-García, I. C., Cacheiro‐Llaguno, C., Fresno, M., & Iñiguez, M. A. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.011 · Cited by 81
Qian, X., Gu, L., Ning, H., Zhang, Y., Hsueh, E. C., Fu, M., Hu, X., Wei, L., Hoft, D. F., & Liu, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203141 · Cited by 81
Kurz, T., Hoffjan, S., Hayes, M. G., Schneider, D., Nicolae, R. I., Heinzmann, A., Jerkic, S. P., Parry, R. R., Cox, N. J., Deichmann, K. A., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.036 · Cited by 78
Nakagawa, N., Yuhki, K., Kawabe, J.-I., Fujino, T., Takahata, O., Kabara, M., Abe, K., Kojima, F., Kashiwagi, H., Hasebe, N., et al. (2012) · Kidney International · doi:10.1038/ki.2012.115 · Cited by 75
Self-citationCyclooxygenase-2 Regulates Th17 Cell Differentiation during Allergic Lung Inflammation
Li, H., Bradbury, J. A., Dackor, R. T., Edin, M. L., Graves, J. P., DeGraff, L. M., Wang, P. M., Bortner, C. D., Maruoka, S., Lih, F. B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1637oc · Cited by 71
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis
Hams, E., Bermingham, R., & Fallon, P. G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00597 · Cited by 70
Zasłona, Z., Serezani, C. H., Okunishi, K., Aronoff, D. M., & Peters-Golden, M. L. (2012) · Blood · doi:10.1182/blood-2011-08-374207 · Cited by 69
Zasłona, Z., Okunishi, K., Bourdonnay, E., Domingo-Gonzalez, R., Moore, B. B., Lukacs, N. W., Aronoff, D. M., & Peters-Golden, M. L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.037 · Cited by 69
Nakajima, S., Honda, T., Sakata, D., Egawa, G., Tanizaki, H., Otsuka, A., Moniaga, C. S., Watanabe, T., Miyachi, Y., Narumiya, S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903260 · Cited by 69
Self-citationProstaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis
Robb, C. T., McSorley, H. J., Lee, J., Aoki, T., Yu, C., Crittenden, S., Astier, A., Felton, J. M., Parkinson, N., Ayele, A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.045 · Cited by 68
Self-citationFever, inflammation, pain and beyond: prostanoid receptor research during these 25 years
Narumiya, S., & Furuyashiki, T. (2011) · The FASEB Journal · doi:10.1096/fj.11-0302ufm · Cited by 65
Self-citationTwo Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma
Kuna, P., Bjermer, L. H., & Tornling, G. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s105142 · Cited by 65
Li, X., Murray, F., Koide, N., Goldstone, J., Dann, S. M., Chen, J., Bertin, S., Fu, G., Weinstein, L. S., Chen, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59097 · Cited by 64
Kotla, S., Singh, N. K., Heckle, M., Tigyi, G., & Rao, G. N. (2013) · Science Signaling · doi:10.1126/scisignal.2004214 · Cited by 63
The IL-23 to IL-17 cascade inflammation-related cancers.
Wang, K., & Karin, M. (2015) · PubMed · Cited by 58
He, R., Oyoshi, M. K., Wang, J. Y. T., Hodge, M. R., Jin, H., & Geha, R. S. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.006 · Cited by 54
The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation
Hernandez, J. B., Chang, C., LeBlanc, M., Grimm, D., Le Lay, J., Kaestner, K. H., Zheng, Y., & Montminy, M. (2015) · Nature Communications · doi:10.1038/ncomms8216 · Cited by 53
Li, H., Edin, M. L., Bradbury, J. A., Graves, J. P., DeGraff, L. M., Gruzdev, A., Cheng, J., Dackor, R. T., Wang, P. M., Bortner, C. D., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2073oc · Cited by 53
Wallace, A. E., Sales, K. J., Catalano, R. D., Anderson, R. A., Williams, A. R. W., Wilson, M., Schwarze, J., Wang, H., Rossi, A. G., & Jabbour, H. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0390 · Cited by 53
CRTH2 Is A Critical Regulator of Neutrophil Migration and Resistance to Polymicrobial Sepsis
Ishii, M., Asano, K., Namkoong, H., Tasaka, S., Mizoguchi, K., Asami, T., Kamata, H., Kimizuka, Y., Fujiwara, H., Funatsu, Y., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102330 · Cited by 52
Gao, Y., Zhao, C., Wang, W., Jin, R., Li, Q., Ge, Q., Guan, Y., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep20505 · Cited by 48
Roper, R. L., Ludlow, J. W., & Phipps, R. P. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1079 · Cited by 47
Glas, J., Seiderer, J., Czamara, D., Pasciuto, G., Diegelmann, J., Wetzke, M., Olszak, T., Wolf, C., Müller‐Myhsok, B., Balschun, T. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052873 · Cited by 47
Prostaglandin I2 analogues enhance already exuberant Th17 cell responses in systemic sclerosis
Truchetet, M., Allanore, Y., Montanari, E., Chizzolini, C., & Brembilla, N. C. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201400 · Cited by 47
Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells
Kofler, D. M., Marson, A., Dominguez‐Villar, M., Xiao, S., Kuchroo, V. K., & Hafler, D. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72973 · Cited by 46
Wang, X., Ni, L., Chang, D., Li, J., Jiang, Y., Kim, B., Wang, A., Liu, X., Zhong, B., Yang, X. O., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.010 · Cited by 46
Genome-Wide Association Study of Multiple Sclerosis Confirms a Novel Locus at 5p13.1
Matesanz, F., González‐Pérez, A., Lucas, M., Sanna, S., Gayán, J., Urcelay, E., Zara, I., Pitzalis, M., Cavanillas, M. L., Arroyo, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036140 · Cited by 45
Kocieda, V., Adhikary, S., Emig, F. A., Yen, J.-H. J., Toscano, M. G., & Ganea, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.402958 · Cited by 44
Zhou, W., Zhang, J., Goleniewska, K., Dulek, D. E., Toki, S., Newcomb, D. C., Cephus, J. Y., Collins, R. D., Wu, P., Boothby, M. R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501063 · Cited by 44
Moalli, F., Cupovic, J., Thelen, F., Halbherr, P., Fukui, Y., Narumiya, S., Ludewig, B., & Stein, J. V. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140137 · Cited by 41
Self-citationMattsson, N., Yaong, M., Rosengren, L., Blennow, K., Mansson, J. E., Andersen, O., Zetterberg, H., Haghighi, S., Zho, I., & Praticò, D. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02035.x · Cited by 39
Monk, J. M., Turk, H. F., Fan, Y.-Y., Callaway, E. S., Weeks, B. R., Yang, P., McMurray, D. N., & Chapkin, R. S. (2014) · Mediators of Inflammation · doi:10.1155/2014/917149 · Cited by 39
Zhou, W., Dowell, D. R., Huckabee, M. M., Newcomb, D. C., Boswell, M. G., Goleniewska, K., Lotz, M. T., Toki, S., Yin, H., Yao, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033518 · Cited by 37
Minamino, T., Ito, Y., Ohkubo, H., Hosono, K., Suzuki, T., Sato, T., Ae, T., Shibuya, A., Sakagami, H., Narumiya, S., et al. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.013 · Cited by 33
Self-citationYang, Q., Shi, M., Shen, Y., Cao, Y., Zuo, S., Zuo, C., Zhang, H., Gabrilovich, D. I., Yu, Y., & Zhou, J. (2014) · Blood · doi:10.1182/blood-2014-03-559658 · Cited by 28
Rodríguez‐Rodríguez, L., Cortés, J. I., Carmona, F. D., Martin, J. J., Balsa, A., van Steenbergen, H. W., Mil, A. H. M. V. D. H., González‐Álvaro, I., & Fernández‐Gutiérrez, B. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0830-z · Cited by 27
Ogawa, Y., Suzuki, T., Oikawa, A., Hosono, K., Kubo, H., Amano, H., Ito, Y., Kitasato, H., Hayashi, I., Kato, T., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.094 · Cited by 26
Self-citationMa, X., Aoki, T., & Narumiya, S. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.70 · Cited by 25
Self-citationMagari, M., Nishikawa, Y., Fujii, Y., Nishio, Y., Watanabe, K., Fujiwara, M., Kanayama, N., & Ohmori, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100934 · Cited by 23
Chai, W., Lian, Z., Chen, C., Liu, J., Shi, L. L., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074794 · Cited by 21
Prostaglandin I 2 suppresses the development of diet‐induced nonalcoholic steatohepatitis in mice
Kumei, S., Yuhki, K., Kojima, F., Kashiwagi, H., Imamichi, Y., Okumura, T., Narumiya, S., & Ushikubi, F. (2017) · The FASEB Journal · doi:10.1096/fj.201700590r · Cited by 17
Self-citation
Cited by
Rodriguez-Martin, N. M., Montserrat-de la Paz, S., Toscano, R., Grao-Cruces, E., Villanueva, A., Pedroche, J., Millan, F., & Millan-Linares, M. C. (2020) · Biomolecules · doi:10.3390/biom10050803 · Cited by 61
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Liu, N., Tang, J., Xue, Y., Mok, V., Zhang, M., Ren, X., Wang, Y., & Fu, J. (2022) · Aging and disease · doi:10.14336/ad.2021.0627 · Cited by 15
Metadata
- Authors
- Yao, C., & Narumiya, S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2018-12-18
- Volume
- 176
- Issue
- 3
- Pages
- 337-354
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2899412362
- Cited by
- 283
- References
- 140
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.